LAUREN CLERMONT: Open Payments
NPI 1821419342 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 15 payments from 11 companies in 2025. Trend: 2023 $1,088 · 2024 $597 · 2025 $1,247
Consulting: $620Food & beverage: $271Education: $201Speaker / faculty: $154
| Company | Payments | Amount |
|---|---|---|
| KYOWA KIRIN, INC. | 1 | $620 |
| AstraZeneca Pharmaceuticals LP | 2 | $177 |
| Lilly USA, LLC | 2 | $126 |
| Astellas Pharma US Inc | 1 | $93 |
| Kite Pharma, Inc. | 2 | $52 |
| Genentech USA, Inc. | 2 | $46 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
| Genmab U.S., Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $28 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $23 |
Products named: POTELIGEO, EPKINLY, Yescarta, RYLAZE, Polivy, CALQUENCE, ZYNLONTA, Lenvima.
Industry payments across WA — which companies pay providers there.
